Trials / Completed
CompletedNCT01576055
Evaluation of the GORE TIGRIS Vascular Stent
Evaluation of the GORE TIGRIS Vascular Stent in the Treatment of Atherosclerotic Lesions of the Superficial Femoral and Proximal Popliteal Arteries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 267 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the randomized study is to evaluate the safety and effectiveness of the TIGRIS Vascular Stent in the treatment of de novo and restenotic atherosclerotic lesions, ≤ 24cm in length, in the superficial femoral and proximal popliteal arteries (SFA/PPA) of patients with symptomatic peripheral arterial disease (PAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TIGRIS Vascular Stent | Implant |
| DEVICE | BARD LifeStent | Implant |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-08-01
- Completion
- 2017-08-01
- First posted
- 2012-04-12
- Last updated
- 2017-10-09
- Results posted
- 2016-10-19
Locations
34 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01576055. Inclusion in this directory is not an endorsement.